Condensed Consolidated Statements of Cash Flows $ in Thousands	9 Months Ended
	Sep. 30, 2016 USD ($)	Sep. 30, 2015 USD ($)
Cash flows from operating activities:
Net (loss) income	$ (20,148)	$ (13,315)
Adjustments to reconcile net loss to net cash provided by operating activities:
Change in allowance for doubtful accounts	146	167
Change in the fair value of acquisition-related contingent consideration	(213)	(674)
Amortization of the fair value adjustment related to warranty liabilities acquired through acquisitions	(57)	(12)
Amortization of deferred financing fees	611	348
Depreciation and amortization	31,668	19,426
Impairment loss - satellite network	10,680	12,748
Stock-based compensation	3,824	3,214
Foreign exchange loss (gain)	482	(419)
Deferred income taxes	538	62
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(3,925)	3,408
Inventories	(336)	(4,275)
Prepaid expenses and other assets	134	(470)
Accounts payable and accrued liabilities	(1,013)	(8,730)
Deferred revenue	(2,540)	(118)
Other liabilities	(664)	(175)
Net cash provided by operating activities	19,187	11,185
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired	(3,452)	(133,078)
Capital expenditures	(22,519)	(32,106)
Cash held for acquisition		123,000
Change in restricted cash	1,000
Other	(198)
Net cash used in investing activities	(25,169)	(42,184)
Cash flows from financing activities:
Proceeds received from issuance of long-term debt		10,000
Cash paid for debt issuance costs		(842)
Proceeds received from exercise of stock options		244
Payment of deferred purchase consideration	(342)	(1,106)
Principal payment of note payable		(10,000)
Principal payments of capital leases		(72)
Net cash used in financing activities	(342)	(1,776)
Effect of exchange rate changes on cash and cash equivalents	520	(300)
Net decrease in cash and cash equivalents	(5,804)	(33,075)
Beginning of period	27,077	91,565
End of period	21,273	58,490
Cash paid for
Interest	6,581	6,747
Income taxes	(110)	584
Noncash investing and financing activities:
Capital expenditures incurred not yet paid	1,090	2,030
Capital expenditure milestone payable incurred not yet paid	5,070	130
Stock-based compensation related to capital expenditures	219	27
Series A convertible preferred stock dividend paid in kind	7
Common stock issued as payment for MPUs		358
Common stock issued as payment for contingent consideration	352	$ 542
Acquisition-related contingent consideration	$ 514